President and Chief Executive Officer
Michael Singer has brought more than 20 years of executive leadership, healthcare and financial experience to BrainScope. During his five year tenure at BrainScope, he has been instrumental in guiding the company through development and clinical validation of a product to aid in the assessment of Traumatic Brain Injury, while securing venture capital investment and research funding through military contracts. Before he joined BrainScope, he was President of Revolution Health Investments, where he managed its sale to Everyday Health. He was previously the Chief Financial Officer, Executive Vice President of Corporate Development and a Board member for Data Critical, a Seattle-based venture-backed wireless healthcare informatics and medical device company. At Data Critical he was responsible for facilitating the company’s IPO, overseeing all financial functions, managing acquisitions and partnerships and eventually led the sale of Data Critical to GE. He has also worked as an executive at Microsoft Corporation responsible for developing small business and healthcare strategies, and for a decade as a healthcare investment banker and M&A generalist for Wolfensohn & Co., Montgomery Securities and Alex. Brown in New York and San Francisco. He started his career at Union Bank of Switzerland in Zurich. He holds a Ph.D. from the London School of Economics.
Senior Vice President, Commercial Product Development and Manufacturing
Bill Koppes brings more than 30 years of medical product development and commercial product support experience to Brainscope. He has led R&D organizations ranging from start-ups to large international teams and has worked across a range of product categories including diagnostic imaging, patient monitoring, electronic medical records and in-vitro diagnostics. He most recently was VP of Global Research and Development for Siemens Healthcare Diagnostics where he was responsible for instrument, software, and consumables development for Chemistry, Immunochemistry, Laboratory Automation and Informatics products. Among his key achievements at Siemens Diagnostics was the integration of three separate R&D organizations following Siemens acquisition of Dade Behring, Bayer Diagnostics, and Diagnostic Products Corporation in 2006/2007.
Prior to his role at Siemens, Mr. Koppes was VP of Global Engineering at Dade Behring where he led the development of Chemistry, Immunochemistry, Plasma Protein, Hemostasis and Microbiology products. He also served on the Chemistry/Immunochemistry Business Operations Team and chaired the Chemistry/Immunochemistry Product Strategy Team. Prior to joining Dade Behring in 1999, Mr. Koppes held a variety of management roles within the Ultrasound Imaging, Patient Monitoring, and Clinical Information Systems Divisions of Hewlett Packard's Medical Products Group (now Philips Medical).
Mr. Koppes holds a B.S. in Electrical Engineering from the University of Washington and an M.S. in Electrical Engineering from the University of California, Berkeley.
Douglas C. Oberly, M.S.
Vice President, Clinical Affairs
Mr. Oberly brings over 15 years of clinical experience in the areas of Critical Care, Emergency Medicine, and Air Medical Transport. He most recently served as a Clinical Specialist with Respironics, Inc. providing education and sales support for the Critical Care Division. He was also a Clinical Manager at Hartford Hospital in Hartford, Connecticut overseeing clinical practice, research, and education. He has provided clinical consulting in the areas of product development and clinical utility to numerous medical device and pharmaceutical companies. He has received research and presentation awards from the American College of CHEST Physicians and the Undersea Hyperbaric Medicine Society.
Mr. Oberly received his M.S. in Management from Rensselaer Polytechnic Institute Lally School of Management & Technology, and his B.S. degree in Respiratory Therapy from York College of Pennsylvania.